These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 14996699)

  • 1. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.
    Paul M; Benuri-Silbiger I; Soares-Weiser K; Leibovici L
    BMJ; 2004 Mar; 328(7441):668. PubMed ID: 14996699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
    Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
    Paul M; Soares-Weiser K; Leibovici L
    BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
    Paul M; Lador A; Grozinsky-Glasberg S; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003344. PubMed ID: 24395715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
    Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
    Falagas ME; Matthaiou DK; Bliziotis IA
    J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
    Marcus R; Paul M; Elphick H; Leibovici L
    Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
    Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
    Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
    Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
    Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
    DeJace P; Klastersky J
    Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections.
    Falagas ME; Matthaiou DK; Karveli EA; Peppas G
    Aliment Pharmacol Ther; 2007 Mar; 25(5):537-56. PubMed ID: 17305755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.
    Jiao Y; Moya B; Chen MJ; Zavascki AP; Tsai H; Tao X; Sutaria DS; Louie A; Boyce JD; Deveson Lucas D; Kim TH; Tsuji BT; Bonomo RA; Drusano GL; Bulitta JB
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
    Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials.
    Shiber S; Yahav D; Avni T; Leibovici L; Paul M
    J Antimicrob Chemother; 2015 Jan; 70(1):41-7. PubMed ID: 25261419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.
    Vidal L; Gafter-Gvili A; Borok S; Fraser A; Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Aug; 60(2):247-57. PubMed ID: 17562680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L; Paul M; Poznanski O; Drucker M; Samra Z; Konigsberger H; Pitlik SD
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.